Damora Therapeutics, Inc. (DMRA) — Financial Flexibility Index
Damora Therapeutics, Inc. (DMRA) has a Financial Flexibility Index of 0.03x as of December 2025. Free cash flow of $566.00K (operating CF $566.00K minus capex $0.00) represents 0% of total liabilities ($20.15 Million). Check Damora Therapeutics, Inc. strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Damora Therapeutics, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Damora Therapeutics, Inc. across 8 annual periods. See Damora Therapeutics, Inc. short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Damora Therapeutics, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Damora Therapeutics, Inc.. For the full company profile including market capitalisation, see Damora Therapeutics, Inc. (DMRA) total market value.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.33x | $-6.73 Million | $-6.73 Million | $20.15 Million | ▲ +95.2% |
| 2024 | -7.00x | $-18.62 Million | $-18.62 Million | $2.66 Million | ▼ -11.8% |
| 2023 | -6.26x | $-36.91 Million | $-36.91 Million | $5.90 Million | ▼ -67.5% |
| 2022 | -3.74x | $-42.74 Million | $-42.93 Million | $11.44 Million | ▲ +64.2% |
| 2021 | -10.43x | $-52.09 Million | $-52.31 Million | $4.99 Million | ▼ -66.8% |
| 2020 | -6.26x | $-38.20 Million | $-38.20 Million | $6.11 Million | ▼ -163.4% |
| 2019 | -2.37x | $-19.33 Million | $-19.33 Million | $8.14 Million | ▲ +22.9% |
| 2018 | -3.08x | $-13.69 Million | $-13.69 Million | $4.44 Million | — |